Background: CD147 contributes to increased aerobic glycolysis through which it promotes tumor growth. Accumulating evidence suggests that CD147 exerts a variety of functions in thyroid cancer (TC) progression but the molecular mechanisms and therapeutic value of CD147 remain unclear.
Methods: CD147 levels in TC tissues were analyzed to assess its relationship with prognosis and disease progression.